AngioDynamics ANGO Proceeds from exercise of stock options and employee stock purchase plan
Proceeds from exercise of stock options and employee stock purchase plan at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:ProceedsPaymentsIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised.
The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan?
- AngioDynamics (ANGO) reported proceeds from exercise of stock options and employee stock purchase plan of $233.25K in Q1 2025.
- How has AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan changed year-over-year?
- AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan increased by 24.1% year-over-year, from $188K to $233.25K.
- What is the long-term trend for AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan?
- Over 4 years (2021 to 2025), AngioDynamics's proceeds from exercise of stock options and employee stock purchase plan has grown at a -25.4% compound annual growth rate (CAGR), from $3.01M to $933K.
- What does proceeds from exercise of stock options and employee stock purchase plan mean?
- This captures the cash received from employees exercising stock options or participating in employee stock purchase plans. It reflects the alignment between employee compensation and equity ownership. A consistent inflow here indicates healthy employee participation in equity-based incentive programs.